Quanterix (QTRX) Competitors

Cytek Biosciences has higher revenue and earnings than Quanterix. Cytek Biosciences is trading at a lower price-to-earnings ratio than Quanterix, indicating that it is currently the more affordable of the two stocks.

Cytek Biosciences currently has a consensus price target of $5.69, indicating a potential upside of 26.81%. Quanterix has a consensus price target of $4.00, indicating a potential downside of 0.50%. Given Cytek Biosciences' stronger consensus rating and higher probable upside, equities analysts clearly believe Cytek Biosciences is more favorable than Quanterix.

Cytek Biosciences has a net margin of -36.25% compared to Quanterix's net margin of -71.86%. Cytek Biosciences' return on equity of -10.07% beat Quanterix's return on equity.

In the previous week, Quanterix had 2 more articles in the media than Cytek Biosciences. MarketBeat recorded 4 mentions for Quanterix and 2 mentions for Cytek Biosciences. Cytek Biosciences' average media sentiment score of 0.96 beat Quanterix's score of 0.54 indicating that Cytek Biosciences is being referred to more favorably in the media.

69.5% of Cytek Biosciences shares are owned by institutional investors. Comparatively, 86.5% of Quanterix shares are owned by institutional investors. 10.4% of Cytek Biosciences shares are owned by company insiders. Comparatively, 1.5% of Quanterix shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Cytek Biosciences has a beta of 1.17, meaning that its stock price is 17% more volatile than the broader market. Comparatively, Quanterix has a beta of 1.04, meaning that its stock price is 4% more volatile than the broader market.

Frequency Electronics has lower revenue, but higher earnings than Quanterix. Frequency Electronics is trading at a lower price-to-earnings ratio than Quanterix, indicating that it is currently the more affordable of the two stocks.

In the previous week, Frequency Electronics had 8 more articles in the media than Quanterix. MarketBeat recorded 12 mentions for Frequency Electronics and 4 mentions for Quanterix. Quanterix's average media sentiment score of 0.54 beat Frequency Electronics' score of 0.00 indicating that Quanterix is being referred to more favorably in the media.

Quanterix presently has a consensus price target of $4.00, indicating a potential downside of 0.50%. Frequency Electronics has a consensus price target of $43.67, indicating a potential downside of 43.36%. Given Quanterix's higher probable upside, analysts clearly believe Quanterix is more favorable than Frequency Electronics.

Frequency Electronics has a net margin of -1.43% compared to Quanterix's net margin of -71.86%. Frequency Electronics' return on equity of -1.55% beat Quanterix's return on equity.

86.5% of Quanterix shares are held by institutional investors. Comparatively, 58.6% of Frequency Electronics shares are held by institutional investors. 1.5% of Quanterix shares are held by company insiders. Comparatively, 28.0% of Frequency Electronics shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Quanterix has a beta of 1.04, indicating that its share price is 4% more volatile than the broader market. Comparatively, Frequency Electronics has a beta of 0.71, indicating that its share price is 29% less volatile than the broader market.

86.5% of Quanterix shares are owned by institutional investors. 0.8% of Syntec Optics shares are owned by insiders. Comparatively, 1.5% of Quanterix shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Quanterix has a consensus target price of $4.00, indicating a potential downside of 0.50%. Given Quanterix's stronger consensus rating and higher probable upside, analysts clearly believe Quanterix is more favorable than Syntec Optics.

Syntec Optics has higher earnings, but lower revenue than Quanterix. Syntec Optics is trading at a lower price-to-earnings ratio than Quanterix, indicating that it is currently the more affordable of the two stocks.

Syntec Optics has a net margin of -10.95% compared to Quanterix's net margin of -71.86%. Quanterix's return on equity of -23.92% beat Syntec Optics' return on equity.

In the previous week, Quanterix had 4 more articles in the media than Syntec Optics. MarketBeat recorded 4 mentions for Quanterix and 0 mentions for Syntec Optics. Syntec Optics' average media sentiment score of 1.00 beat Quanterix's score of 0.54 indicating that Syntec Optics is being referred to more favorably in the media.

Syntec Optics has a beta of -0.86, indicating that its share price is 186% less volatile than the broader market. Comparatively, Quanterix has a beta of 1.04, indicating that its share price is 4% more volatile than the broader market.

Quanterix presently has a consensus price target of $4.00, suggesting a potential downside of 0.50%. Standard BioTools has a consensus price target of $1.35, suggesting a potential upside of 58.26%. Given Standard BioTools' higher probable upside, analysts clearly believe Standard BioTools is more favorable than Quanterix.

Quanterix has a beta of 1.04, indicating that its stock price is 4% more volatile than the broader market. Comparatively, Standard BioTools has a beta of 1.42, indicating that its stock price is 42% more volatile than the broader market.

Standard BioTools has lower revenue, but higher earnings than Quanterix. Quanterix is trading at a lower price-to-earnings ratio than Standard BioTools, indicating that it is currently the more affordable of the two stocks.

In the previous week, Quanterix and Quanterix both had 4 articles in the media. Standard BioTools' average media sentiment score of 1.44 beat Quanterix's score of 0.54 indicating that Standard BioTools is being referred to more favorably in the news media.

Standard BioTools has a net margin of 73.46% compared to Quanterix's net margin of -71.86%. Standard BioTools' return on equity of -8.18% beat Quanterix's return on equity.

86.5% of Quanterix shares are owned by institutional investors. Comparatively, 53.7% of Standard BioTools shares are owned by institutional investors. 1.5% of Quanterix shares are owned by insiders. Comparatively, 26.8% of Standard BioTools shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.